SNM SCANcast: New PET synthesizer readies for market entry
A new, compact synthesizer of PET radiotracers -- about a third the size of systems currently available -- is poised to enter the U.S. market later this year. Hear an interview with its inventor, Maxim Kiselev, Ph.D., vice president of R&D for IBA Molecular.
A new, compact synthesizer of PET radiotracers - about a third the size of systems currently available - is poised to enter the U.S. market later this year. Synthera, developed by IBA (Ion Beam Applications) Molecular and priced at about $96,000, was unveiled at the Society of Nuclear Medicine meeting June 3 to 7 in San Diego. Its core component, the ejectable Integrated Fluidic Processor, makes it a true multirun system capable of producing various radiotracers, including FDG, according to its inventor, Maxim Kiselev, Ph.D., vice president of R&D for IBA Molecular. (hear a two-minute interview with Kiselev from the SNM exhibit floor)
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
